NDT Pharmaceuticals Valuation
| NDTP Stock | USD 0.95 0.01 1.06% |
Today, the firm appears to be overvalued. NDT Pharmaceuticals secures a last-minute Real Value of $0.91 per share. The latest price of the firm is $0.95. Our model forecasts the value of NDT Pharmaceuticals from inspecting the firm fundamentals such as Current Valuation of 123.75 K, number of employees of 4, and Shares Outstanding of 1.12 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that NDT Pharmaceuticals' price fluctuation is out of control at this time. Calculation of the real value of NDT Pharmaceuticals is based on 3 months time horizon. Increasing NDT Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
NDT Pharmaceuticals' intrinsic value may or may not be the same as its current market price of 0.95, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.95 | Real 0.91 | Hype 0.95 |
The intrinsic value of NDT Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence NDT Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of NDT Pharmaceuticals helps investors to forecast how NDT pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NDT Pharmaceuticals more accurately as focusing exclusively on NDT Pharmaceuticals' fundamentals will not take into account other important factors: About NDT Pharmaceuticals Valuation
The pink sheet valuation mechanism determines NDT Pharmaceuticals' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of NDT Pharmaceuticals based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of NDT Pharmaceuticals. We calculate exposure to NDT Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of NDT Pharmaceuticals's related companies.NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. Ndt Pharmaceuticals is traded on OTC Exchange in the United States.
8 Steps to conduct NDT Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates NDT Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct NDT Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain NDT Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine NDT Pharmaceuticals' revenue streams: Identify NDT Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research NDT Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish NDT Pharmaceuticals' growth potential: Evaluate NDT Pharmaceuticals' management, business model, and growth potential.
- Determine NDT Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate NDT Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for NDT Pink Sheet Analysis
When running NDT Pharmaceuticals' price analysis, check to measure NDT Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NDT Pharmaceuticals is operating at the current time. Most of NDT Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NDT Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NDT Pharmaceuticals' price. Additionally, you may evaluate how the addition of NDT Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.